Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging

• Autores: Alexandra M. V. Wennberg, Rodolfo Savica, Clinton E. Hagen, Rosebud O. Roberts, David S. Knopman, John H. Hollman, Prashanthi Vemuri, Clifford R. Jack, Ronald C. Petersen, Michelle M. Mielke
• Localización: Journal of the American Geriatrics Society, ISSN 0002-8614, Vol. 65, Nº. 4, 2017, págs. 792-799
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • Objectives To determine the cross-sectional association between cerebral amyloid-beta (Aβ) deposition and gait.

    Design Cross-sectional.

    Setting Population-based cohort study in Olmsted County, MN.

    Participants Cognitively normal individuals (n = 611), aged 50 to 69 years, enrolled in the Mayo Clinic Study of Aging with concurrent PiB-PET imaging and gait assessment. Participants with a history of stroke, alcoholism, Parkinson's disease, subdural hematoma, traumatic brain injury, or normal pressure hydrocephalus were excluded.

    Measurements PiB-PET SUVR was measured in prefrontal, orbitofrontal, parietal, temporal, anterior cingulate, posterior cingulate, and motor-specific regions of interest (ROIs). Gait parameters (speed, cadence, stride length, double support time, and intra-individual stance time variability) were measured using GAITRite® instrumentation. Linear regression models were adjusted for age, sex, body mass index, education, APOE ε4 allele, Charlson comorbidity index, and depression. In secondary analyses, we additionally adjusted for neurodegeneration (hippocampal volume, FDG PET SUVR, and cortical thickness) in AD-associated regions.

    Results In fully adjusted models including neuroimaging measures of neurodegeneration, higher PiB-PET SUVR across all ROIs was associated with slower gait speed (P < .05 except for the parietal ROI), lower cadence and longer double support time (P ≤ .05 except for the motor ROI), and greater stance time variability (P < .05). In sex-stratified analyses, the association between higher PiB-PET SUVR across all ROIs and measures of gait was only present among women.

    Conclusion PiB-PET SUVR across ROIs, independent of general measures of AD-associated neurodegeneration, is associated with poorer performance on multiple gait parameters among cognitively normal women, aged 50 to 69 years. Longitudinal studies are needed to determine whether Aβ predicts gait decline in both women and men.